Protalix (PLX) stock analysis highlights profit margins, institutional activity, technical analysis alongside daily market intelligence and earnings coverage. Protalix BioTherapeutics Inc. (DE) (PLX) closed at $2.14, rising 1.90% in the latest session. The stock continues to trade within recent range, with established support at $2.03 and resistance at $2.25. The move comes amid broader interest in small‑cap biotechnology names.
Protalix BioTherapeutics (PLX) Gains on Biotechnology Sector Momentum – Key Levels in Focus - ATR Stop
PLX - Stock Analysis
3324 Comments
873 Likes
1
{用户名称}
{用户等级}
2 hours ago
{协议答案}
👍 289
Reply
2
{用户名称}
{用户等级}
5 hours ago
{协议答案}
👍 57
Reply
3
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 47
Reply
4
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 234
Reply
5
{用户名称}
{用户等级}
2 days ago
{协议答案}
👍 185
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.